The Valvular Heart Disease in Women (VHD-W) Registry: a global initiative to address gender disparities in management and outcomes.

ABSTRACT:

Aims

Valvular heart disease is a leading cause of cardiovascular morbidity and mortality globally, with women experiencing delayed referrals, difficulties recognizing atypical symptoms, and suboptimal adherence to guideline-based therapies, resulting in worse outcomes. However, the literature identifying these disparities remains limited, underscoring the need for a comprehensive registry to address these gaps. The Valvular Heart Disease in Women Registry (VHD-W) aims to provide real-world insights into gender differences by examining treatment patterns, guideline adherence, and clinical results.

Methods and results

The VHD-W is an international, multicenter, non-commercial, investigator-initiated, multipurpose registry endorsed by the European Association of Cardiovascular

SUBMITTER: Anwer S 

PROVIDER: S-EPMC12679912 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature